149 related articles for article (PubMed ID: 8489524)
1. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
Hu P; Margolis B; Schlessinger J
Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
[TBL] [Abstract][Full Text] [Related]
2. Vav: function and regulation in hematopoietic cell signaling.
Bonnefoy-Bérard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
[TBL] [Abstract][Full Text] [Related]
3. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
4. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
Uddin S; Yetter A; Katzav S; Hofmann C; White MF; Platanias LC
Exp Hematol; 1996 Apr; 24(5):622-7. PubMed ID: 8605967
[TBL] [Abstract][Full Text] [Related]
6. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
7. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization.
Adams JM; Houston H; Allen J; Lints T; Harvey R
Oncogene; 1992 Apr; 7(4):611-8. PubMed ID: 1565462
[TBL] [Abstract][Full Text] [Related]
8. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells.
Gulbins E; Langlet C; Baier G; Bonnefoy-Berard N; Herbert E; Altman A; Coggeshall KM
J Immunol; 1994 Mar; 152(5):2123-9. PubMed ID: 8133029
[TBL] [Abstract][Full Text] [Related]
10. Vav: Captain Hook for signal transduction?
Katzav S
Crit Rev Oncog; 1995; 6(2):87-97. PubMed ID: 8792085
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.
Machide M; Mano H; Todokoro K
Oncogene; 1995 Aug; 11(4):619-25. PubMed ID: 7651724
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of Ras activation by tyrosine phosphorylated Vav.
Gulbins E; Schlottmann K; Brenner B; Lang F; Coggeshall KM
Biochem Biophys Res Commun; 1995 Dec; 217(3):876-85. PubMed ID: 8554611
[TBL] [Abstract][Full Text] [Related]
13. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
Crespo P; Schuebel KE; Ostrom AA; Gutkind JS; Bustelo XR
Nature; 1997 Jan; 385(6612):169-72. PubMed ID: 8990121
[TBL] [Abstract][Full Text] [Related]
14. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
Groysman M; Nagano M; Shaanan B; Katzav S
Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237
[TBL] [Abstract][Full Text] [Related]
16. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of activation of the vav protooncogene.
Coppola J; Bryant S; Koda T; Conway D; Barbacid M
Cell Growth Differ; 1991 Feb; 2(2):95-105. PubMed ID: 2069873
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
19. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.
Tarakhovsky A; Turner M; Schaal S; Mee PJ; Duddy LP; Rajewsky K; Tybulewicz VL
Nature; 1995 Mar; 374(6521):467-70. PubMed ID: 7700358
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase signalling pathways.
Pawson T
Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
